These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32416670)

  • 1. Novel Therapeutic Approaches and Targets for Treatment of Vulvar Lichen Sclerosus.
    Borghi A; Corazza M
    Curr Pharm Biotechnol; 2021; 22(1):99-114. PubMed ID: 32416670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growing evidence for topical mometasone fuoroate in the treatment of Vulvar Lichen Sclerosus.
    Virgili A; Corazza M; Minghetti S; Borghi A
    Maturitas; 2015 Jan; 80(1):113-5. PubMed ID: 25449823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An arm-based network meta-analysis on treatments for vulvar lichen sclerosus and a call for development of core outcome sets.
    Pergialiotis V; Bellos I; Biliou EC; Varnava P; Mitsopoulou D; Doumouchtsis SK;
    Am J Obstet Gynecol; 2020 Jun; 222(6):542-550.e6. PubMed ID: 31697910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical interventions for genital lichen sclerosus.
    Chi CC; Kirtschig G; Baldo M; Brackenbury F; Lewis F; Wojnarowska F
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD008240. PubMed ID: 22161424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study.
    Virgili A; Minghetti S; Borghi A; Corazza M
    Br J Dermatol; 2013 Jun; 168(6):1316-24. PubMed ID: 23398459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Topical treatment of vulvar lichen sclerosus with calcineurin inhibitors].
    Maassen MS; van Doorn HC
    Ned Tijdschr Geneeskd; 2012; 156(36):A3908. PubMed ID: 22951124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and dermoscopic changes of vulvar lichen sclerosus after topical corticosteroid treatment.
    Borghi A; Corazza M; Minghetti S; Toni G; Virgili A
    J Dermatol; 2016 Sep; 43(9):1078-82. PubMed ID: 27075682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus.
    Funaro D; Lovett A; Leroux N; Powell J
    J Am Acad Dermatol; 2014 Jul; 71(1):84-91. PubMed ID: 24704090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clobetasol propionate vs. mometasone furoate in 1-year proactive maintenance therapy of vulvar lichen sclerosus: results from a comparative trial.
    Corazza M; Borghi A; Minghetti S; Toni G; Virgili A
    J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):956-61. PubMed ID: 25904498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy in vulvar lichen sclerosus: does topical tretinoin improve the efficacy of mometasone furoate?
    Borghi A; Minghetti S; Toni G; Virgili A; Corazza M
    J Dermatolog Treat; 2017 Sep; 28(6):559-563. PubMed ID: 28024127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus.
    Goldstein AT; Creasey A; Pfau R; Phillips D; Burrows LJ
    J Am Acad Dermatol; 2011 Jun; 64(6):e99-104. PubMed ID: 21353334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mometasone fuoroate 0.1% ointment in the treatment of vulvar lichen sclerosus: a study of efficacy and safety on a large cohort of patients.
    Virgili A; Borghi A; Minghetti S; Corazza M
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):943-8. PubMed ID: 23879234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of vulvar lichen sclerosus in a child with low-concentration topical tacrolimus ointment.
    Matsumoto Y; Yamamoto T; Isobe T; Kusunoki T; Tsuboi R
    J Dermatol; 2007 Feb; 34(2):114-6. PubMed ID: 17239148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vulvar lichen sclerosus: a comparison of the short-term topical application of clobetasol dipropionate 0.05% versus mometasone furoate 0.1%.
    Murina F; Rehman S; Di Francesco S; Mantegazza V; Felice R; Bianco V
    J Low Genit Tract Dis; 2015 Apr; 19(2):149-51. PubMed ID: 25023331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term maintenance therapy for vulvar lichen sclerosus: the results of a randomized study comparing topical vitamin E with an emollient.
    Virgili A; Minghetti S; Borghi A; Corazza M
    Eur J Dermatol; 2013 Apr; 23(2):189-94. PubMed ID: 23607963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulvar lichen sclerosus: 11 women treated with tacrolimus 0.1% ointment.
    Virgili A; Lauriola MM; Mantovani L; Corazza M
    Acta Derm Venereol; 2007; 87(1):69-72. PubMed ID: 17225019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of topical pimecrolimus on inflammatory infiltrate in vulvar lichen sclerosus.
    Kauppila S; Kotila V; Knuuti E; Väre PO; Vittaniemi P; Nissi R
    Am J Obstet Gynecol; 2010 Feb; 202(2):181.e1-4. PubMed ID: 19889396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous vs. tapering application of the potent topical corticosteroid mometasone furoate in the treatment of vulvar lichen sclerosus: results of a randomized trial.
    Borghi A; Corazza M; Minghetti S; Toni G; Virgili A
    Br J Dermatol; 2015 Dec; 173(6):1381-6. PubMed ID: 26280156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus 0.03% ointment for treatment of paediatric lichen sclerosus: a case series and literature review.
    Mazzilli S; Diluvio L; Di Prete M; Rossi P; Orlandi A; Bianchi L; Campione E
    J Int Med Res; 2018 Sep; 46(9):3724-3728. PubMed ID: 30058419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases.
    Goldstein AT; Marinoff SC; Christopher K
    J Reprod Med; 2004 Oct; 49(10):778-80. PubMed ID: 15568399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.